1. Kwak YG et al. Clinical Guidelines for the Antibiotic Treatment for Community-acquired Skin and Soft Tissue Infection Infect Chemother 2017;49(4):301-325.
  2. Ban KA et al. Journal of American college of surgeons 2017;224:59-74.Stevens DL, Bisno AL, Chambers HF et al.Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections. Clinical Infectious Diseases 2005; 41:1373–406.
  3. Stevens DL, Bisno AL, Chambers HF et al. Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases June 18 2014.
  4. Lipsky BA, Berendt AR, Cornia PB et al. 2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infections. Clinical Infectious Diseases 2012; 54(12):132–173.
  5. Steven M. Gordon. Antibiotic prophylaxis against postoperative wound infections Cleveland Clinic Journal of Medicine 2006; 73(S1): S42-45.
  6. Joseph S. Solomkin, John E. Mazuski, Ellen J. Baron, Robert G. Sawyer, Avery B. Nathens, Joseph T. DiPiro, et al. Guidelines for the Selection of Anti-infective Agents for Complicated Intra-abdominal Infections Clinical Infectious Diseases 2003, 37:997–1005
  7. Too Y, Tanaka S, Kanematsu A, et al.Antimicrobial prophylaxis to prevent perioperative infection in urological surgery: a multicenter study. J Infect Chemother. 2013 Dec;19(6):1093-101.
  8. Stephanie H Chang, andAlexander S. Krupnick. Perioperative Antibiotics in Thoracic Surgery. Thorac Surg Clin. 2012 February; 22(1): 35–45.
  9. Teena Chopra, Jing J Zhao, George Alangaden, et al. Preventing surgical site infections after bariatric surgery: value of perioperative antibiotic regimens. Expert Rev Pharmacoecon Outcomes Res. 2010 June; 10(3): 317–328.
  10. Saveli CC, Morgan SJ, Belknap RW, Ross E et al. F' J Orthop Trauma. 2013 Oct; 27(10):552-7.
  11. Liu W, Neidert MC, Groen RJ, Woernle CM, Grundmann H. Third-generation cephalosporins as antibiotic prophylaxis in neurosurgery: what's the evidence?Clin Neurol Neurosurg. 2014 Jan; 116:13-9.
  12. Hawn MT, Richman JS, Vick CC, et al. Timing of surgical antibiotic prophylaxis and the risk of surgical site infection. JAMA Surg. 2013 Jul;148(7):649-57.
  13. Mathur P, Trikha V, Farooque K  et al. Implementation of a short course of prophylactic antibiotic treatment for prevention of postoperative infections in clean orthopaedic surgeries. Indian J Med Res. 2013 Jan;137(1):111-6.
  14. Sharma MS, Vohra A, Thomas P, Kapil A et al. Effect of risk-stratified, protocol-based perioperative chemoprophylaxis on nosocomial infection rates in a series of 31 927 consecutive neurosurgical procedures (1994-2006). Neurosurgery. 2009 Jun; 64(6):1123-30.
  15. Gupta A, Hote MP, Choudhury M, Kapil A, Bisoi AK. Comparison of 48 h and 72 h of prophylactic antibiotic therapy in adult cardiac surgery: a randomized double blind controlled trial. J Antimicrob Chemother. 2010 May;65(5):1036-41.
  16. Sharma N, Garg PK, Hadke NS, Choudhary D. Role of prophylactic antibiotics in laparoscopic cholecystectomy and risk factors for surgical site infection: a randomized controlled trial. Surg Infect (Larchmt). 2010 Aug; 11(4):367-70.
  17. Shankar VG, Srinivasan K, Sistla SC, Jagdish S. Prophylactic antibiotics in open mesh repair of inguinal hernia - a randomized controlled trial. Int J Surg. 2010; 8(6):444-7.
  18. National Healthcare Safety Network. Bloodstream Infection Event (Central Line-Associated Bloodstream Infection and Non-Central Line-Associated Bloodstream Infection). http://www.cdc.gov/nhsn/PDFs/pscManual/4PSC_CLABScurrent.pdf
  19. Mermel LA, Allon M, Bouza E, et al (2009). Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 49(1):1-45. doi:10.1086/599376.
  20. Chaves F, Garnacho-Montero J, Del Pozo JL, Bouza E, Capdevila JA, de Cueto M, Domínguez MÁ, Esteban J, et al (2018). Diagnosis and treatment of catheter-related bloodstream infection: Clinical guidelines of the Spanish Society of Infectious Diseases and clinical microbiology and (SEIMC) and the Spanish Society of Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC). Med Intensiva. 42(1):5-36.
  21. Annual report of the Antimicrobial Resistance Surveillance Network January 2017-December 2017: Publication of ICMR-2018
  22. Chakrabarti, A (2015). Incidence, characteristics and outcome of ICU-acquired candidemia in India. Intensive Care Med 41, 285–295.
  23. Falagas ME, Kastoris AC, Kapaskelis AM, Karageorgopoulos DE (2010). Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect Dis. 10: 43–50
  24. Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster M.G, Vazquez JA, Walsh TJ et al (2015). Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin. Infect. Dis. 62, e1–e50.
  25. Harris,P, Tambyah P, Lye,D et al.The MERINO Trial: piperacillin-tazobactam versus meropenem for the definitive treatment of bloodstream infections caused by third generation cephalosporin nonsusceptible Escherichia coli or Klebsiella spp.: an international multi-centre open-label non-inferiority randomised controlled trial. Abstract presented at the ECCMID 2018 Congress.
  26. Meduri GU (1995). Diagnosis and differential diagnosis of ventilator-associated pneumonia. Clin Chest Med16(1):61–93.
  27. Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al (2016). Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 63 (5):e61–111.
  28. Torres A, Niederman MS, Chastre J, Ewig S et al (2017). International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociacion Latinoamericana del Torax (ALAT). Eur Respir J. 10, 50(3).
  29. Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H, et al (2018). Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia. ERJ Open Res 4(2).
  30. Gupta D, Agarwal R, Aggarwal AN, Singh N, Mishra N, Khilnani GC, et al (2012). Pneumonia Guidelines Working Group. Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations. Lung India, 29(Suppl 2): S27-62.
  31. Gupta N, Soneja M, Ray Y, Sahu M, Vinod KS, Kapil A, et al (2018). Nosocomial pneumonia: Search for an empiric and effective antibiotic regimen in the high burden tertiary care centre. Drug Discov Ther 12(2), 97–100.
  32. Pugh R, Grant C, Cooke RPD, Dempsey G (2015). Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults. Cochrane Database Syst Rev 8, CD007577.
  33. Peyrani P, Wiemken TL, Kelley R, Zervos MJ, Kett DH, File TM Jr, Stein GE, Ford KD, Scerpella EG, Welch V, Ramirez JA (2014). IMPACT-HAP Study Group. Higher clinical success in patients with ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus treated with linezolid compared with vancomycin: results from the IMPACT-HAP study. Crit Care 18(3), R118.
  34. Kalpesh S Sukhwani, Nitin Bansal, P Senthur Nambi, Suresh Kumar D, V. Ramasubramanian, Anil Tarigopula, Nandini Sethuraman, Madhumitha R, Ram Gopalakrishnan. Clinical Profile of Clostridium Difficile Associated Diarrhea: A study from Tertiary Care Centre of South India. Tropical Gastroenterology 2018;39(3):135-141
  35. Chaudhry R, Sharma N, Gupta N et al. Nagging presence of Clostridium difficile associated diarrhoea in north India.   Journal of clinical and diagnostic research. 2017; 11(9): 06-09.
  36. Segar L, Easow J, Srirangaraj S, Mohammad Hanifah et al. Prevalence of Clostridium difficile infection among the patients attending a tertiary care teaching hospital. Indian J Pathol Microbiol 2017; 60:221-225.
  37.  Kumar GS, Uma BM. Clostridium difficile: A neglected but emerging pathogen in India. Arch Clin Microbiol 2015; 6: 1-5. 
  38. Tanu Singhal T, Shah S, Tejam R, Thakkar P. Incidence, Epidemiology and Control of Clostridium difficile Infection in a Tertiary Care Private Hospital in India. Indian J of Medical Microbiol 2018;36 (3): 381-384.
  39. McDonald LC, Gerding DN, Johnson S et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 2018;66(7):e1–e48
  40. Saeam Shin, M.D., Minkyung Kim, M.T., Myungsook Kim et al. Evaluation of the Xpert Clostridium difficile Assay for the Diagnosis of Clostridium difficle Infection. Ann Lab Med 2012; 32:355-358.
  41. Parida S, Mishra SK. Urinary tract infections in the critical care unit: A brief review. Indian J Crit Care Med. 2013;17(6):370–4.
  42. Mehta Y, Jaggi N, Rosenthal VD, Kavathekar M, Sakle A, Munshi N, et al. Device-Associated Infection Rates in 20 Cities of India, Data Summary for 2004–2013: Findings of the International Nosocomial Infection Control Consortium. Infection Control & Hospital Epidemiology. 2016 Feb;37(2):172–81
  43. Tenke P, Bjerklund Johansen TE, Matsumoto T, Tambyah PA, Naber KG, European Urologist Association, Urologist Association of Asia. [European and Asian guidelines on management and prevention of catheter-associated urinary tract infections]. Urologiia. 2008 Dec;(6):84–91
  44. Urinary tract infection (catheter-associated urinary tract infection [CAUTI] Centers for Disease Control and Prevention, Atlanta, GAhttp://www. cdcgov/nhsn/PDFs/pscManual/7pscCAUTIcurrent. pdf. 2015
  45. Nicolle LE. Catheter associated urinary tract infections. Antimicrob Resist Infect Control. 2014 Jul 25;3:23
  46. Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America | Clinical Infectious Diseases | Oxford Academic . Available from: https://academic.oup.com/cid/article/50/5/625/324341
  47. Lo E, Nicolle LE, Coffin SE, Gould C, Maragakis LL, Meddings J, et al. Strategies to Prevent Catheter-Associated Urinary Tract Infections in Acute Care Hospitals: 2014 Update. Infection Control & Hospital Epidemiology. 2014 May;35(05):464–79.
  48. Gould CV, Umscheid CA, Agarwal RK, Kuntz G, Pegues DA. Guideline for Prevention of Catheter-Associated Urinary Tract Infections. 2009;61.
  49. Bonkat G, Pickard R, Bartoletti R, Bruyère F, Geerlings SE, Wagenlehner, European association of urology guidelines on urological infections. European Association of Urology. 2017:22-6.
  50. Urinary Tract Infections - ACCP By Helen S. Lee, Pharm. D., BCPS-AQ ID; and Jennifer Le, Pharm. D., MAS 2018.
  51. Treatment guidelines for antimicrobial use in common syndromes. Indian Council of Medical Research, 2017. http://www.icmr.nic.in/guidelines/treatment% 20guidelines %20for%20antimicrobial. Pdf